Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
HC Wainwright & Co. Maintains Buy on Epizyme, Lowers Price Target to $10
HC Wainwright & Co. analyst Andrew Fein maintains Epizyme (NASDAQ:EPZM) with a Buy and lowers the price target from $15 to $10.
Recap: Epizyme Q4 Earnings
Epizyme (NASDAQ:EPZM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the holiday-shortened week before making a comeback.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Cidara Therapeutics (NASDAQ:CDTX) stock moved upwards by 14.1% to $0.91 during Thursday's after-market session. The company's market cap stands at $60.6 million.
54 Biggest Movers From Yesterday
Gainers
MDJM Ltd (NASDAQ: MDJH) shares surged 35.6% to close at $2.44 on Wednesday after gaining 10% on Tuesday.
GWG Holdings, Inc. (NASDAQ: GWGH) gained 31.6% to settle at $4.50.
33 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
MDJM Ltd (NASDAQ: MDJH) jumped 27.2% to $2.29 after gaining 10% on Tuesday.
